vs
Side-by-side financial comparison of Avidbank Holdings, Inc. (AVBH) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Avidbank Holdings, Inc. is the larger business by last-quarter revenue ($28.0M vs $20.6M, roughly 1.4× Entrada Therapeutics, Inc.). Avidbank Holdings, Inc. runs the higher net margin — 32.3% vs -84.4%, a 116.6% gap on every dollar of revenue.
Avidbank Holdings, Inc. is a U.S.-based financial holding company operating through its subsidiary AvidBank. It offers commercial banking products and services primarily to small and medium-sized enterprises, business owners, and high-net-worth individuals across California, including commercial loans, deposit accounts, cash management, and customized financing solutions for sectors like manufacturing, technology, real estate and professional services.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
AVBH vs TRDA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $28.0M | $20.6M |
| Net Profit | $9.0M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | — | -106.0% |
| Net Margin | 32.3% | -84.4% |
| Revenue YoY | — | -65.2% |
| Net Profit YoY | 65.9% | -173.8% |
| EPS (diluted) | $0.84 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $28.0M | — | ||
| Q4 25 | $26.8M | — | ||
| Q3 25 | $48.0K | — | ||
| Q2 25 | $21.8M | — | ||
| Q1 25 | — | $20.6M | ||
| Q4 24 | — | $37.4M | ||
| Q3 24 | — | $19.6M | ||
| Q2 24 | — | $94.7M |
| Q1 26 | $9.0M | — | ||
| Q4 25 | $6.9M | — | ||
| Q3 25 | $-37.7M | — | ||
| Q2 25 | $5.8M | — | ||
| Q1 25 | — | $-17.3M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | $55.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -110491.7% | — | ||
| Q2 25 | 38.0% | — | ||
| Q1 25 | — | -106.0% | ||
| Q4 24 | — | -15.7% | ||
| Q3 24 | — | -110.7% | ||
| Q2 24 | — | 56.4% |
| Q1 26 | 32.3% | — | ||
| Q4 25 | 25.9% | — | ||
| Q3 25 | -78614.6% | — | ||
| Q2 25 | 26.6% | — | ||
| Q1 25 | — | -84.4% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | -71.7% | ||
| Q2 24 | — | 58.1% |
| Q1 26 | $0.84 | — | ||
| Q4 25 | $0.65 | — | ||
| Q3 25 | $-4.12 | — | ||
| Q2 25 | $0.75 | — | ||
| Q1 25 | — | $-0.42 | ||
| Q4 24 | — | $-0.20 | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $1.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $67.8M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $287.2M | $417.3M |
| Total Assets | $2.5B | $486.5M |
| Debt / EquityLower = less leverage | 0.19× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $67.8M | ||
| Q4 24 | — | $101.2M | ||
| Q3 24 | — | $78.0M | ||
| Q2 24 | — | $185.3M |
| Q1 26 | $55.0M | — | ||
| Q4 25 | $60.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $287.2M | — | ||
| Q4 25 | $278.4M | — | ||
| Q3 25 | $273.1M | — | ||
| Q2 25 | $204.4M | — | ||
| Q1 25 | — | $417.3M | ||
| Q4 24 | — | $428.7M | ||
| Q3 24 | — | $422.4M | ||
| Q2 24 | — | $429.9M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | — | $486.5M | ||
| Q4 24 | — | $526.3M | ||
| Q3 24 | — | $554.6M | ||
| Q2 24 | — | $582.0M |
| Q1 26 | 0.19× | — | ||
| Q4 25 | 0.22× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-38.5M |
| Free Cash FlowOCF − Capex | — | $-39.7M |
| FCF MarginFCF / Revenue | — | -192.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $12.4M | — | ||
| Q2 25 | $10.7M | — | ||
| Q1 25 | — | $-38.5M | ||
| Q4 24 | — | $-31.6M | ||
| Q3 24 | — | $-24.3M | ||
| Q2 24 | — | $39.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $12.4M | — | ||
| Q2 25 | $10.6M | — | ||
| Q1 25 | — | $-39.7M | ||
| Q4 24 | — | $-32.2M | ||
| Q3 24 | — | $-24.9M | ||
| Q2 24 | — | $38.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 25783.3% | — | ||
| Q2 25 | 48.6% | — | ||
| Q1 25 | — | -192.9% | ||
| Q4 24 | — | -86.2% | ||
| Q3 24 | — | -127.3% | ||
| Q2 24 | — | 41.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 72.9% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | — | 5.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.84× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVBH
| Net Interest Income | $26.5M | 95% |
| Noninterest Income | $1.5M | 5% |
TRDA
Segment breakdown not available.
